Labeling deception and omissions, as well as false informed consent for vaccination and the use of other types of legalized biological and chemical weapons, are significant issues that have been prevalent since the early 20th century. These deceptions often involve the use of ambiguous terminology and arbitrary units of measurement on biological product labels, including vaccines, with the intent to mislead consumers into believing that the contents are identifiable, measurable, stable, non-toxic, and therapeutic.
Labeling fraud and omissions are just a few of the many levels of legalized deception that have accompanied the production of biological products, the fight against infectious diseases, and vaccination laws from 1902 to the present day. When you pull any thread of deception, it inevitably leads to other layers of deceit. It’s impossible to fully describe any layer in a single report. We encourage readers who want to understand the other layers of deception surrounding any word, phrase, unit of measurement, or unit of power described here or in other Bailiwick reports to delve deeper.
To help more people stop taking vaccines and prevent the vaccination of infants and toddlers, it’s crucial that no one gives informed consent without specific information about what exactly is in the individual packaging presented to a specific recipient at a specific time and place.
Biological labeling laws require general, but not specific, information because the specific contents of any package of biological material cannot be determined, identified, or fully characterized at any given time. Scientific methods of identification and measurement can only partially characterize biological organisms and living systems. This limitation is not due to a lack of scientific knowledge or technology that may someday be overcome, but because of the inherent diversity and instability of biological organisms themselves.
Evaluation methods break down samples to obtain limited information. Each aliquot is different from others, even those from the same batch, and each aliquot differs from itself at earlier or later moments of its existence. It is not possible to establish a “dose” based on the mass or volume of the biological material injected, as all the biological material interacts uniquely and unpredictably with the biological processes of each individual recipient.
Living organisms are in a state of constant change. They are born, grow, absorb nutrients, use energy, change shape, and excrete waste. They communicate and interact with other living organisms, and eventually, they die. At any given time, along the entire distribution and production chain of biological products, all these processes occur in vaccine batches and vials.
Biological processes occur rapidly when living organisms are kept at room temperature or body temperature in a laboratory container for processing. When suspended, encapsulated, cooled, or frozen, these processes proceed more slowly. Events resume rapidly as living organisms are thawed, diluted, heated, mixed, and introduced into another, larger living organism.
Since no healthcare professional, military personnel, manufacturer, regulator, or vaccination specialist can know exactly what is in each package at any given time—given the unstable mixtures of living and non-living matter and the impossibility of predicting how each particular living organism will react after injection—none of them can inform the recipient about the exact nature of the product or its effects.
This knowledge has been known to those in the U.S. public health, military, scientific, medical, legal, and financial communities since the beginning of the modern age of vaccination. Consequently, laws have been written and implemented to remove identifying information from product labels for all viruses, serums, toxins, antivenoms, and vaccines since the passage of the Viral-Toxic Drugs Act by Congress in 1902, and from all labels and “fact sheets” for European Union products since the passage of the Emergency Countermeasures Act by Congress in 2003.
For example, during the October 22, 2020, FDA VRBPAC Meeting, Marion Gruber, Director of the FDA’s Center for Biologics Evaluation and Research, stated that in order to issue an Emergency Use Authorization (EUA), the FDA must determine, among other things, that the product may be effective and that the known and potential benefits outweigh its known and potential risks.
The use of an experimental COVID-19 vaccine with a clinical trial authorization does not require informed consent. However, vaccine recipients should be provided with an information leaflet that describes the experimental nature of the drug, the known and potential benefits and risks, the available alternatives, and the option to opt out of vaccination.
Informed consent is the most important and fundamental basis for anyone deciding to undergo medical intervention. For a deeper understanding of this topic, we recommend reading the book “The War on Informed Consent” by Jeremy R. Hammond.
For more detailed information, you can visit the original article on Bailiwick News.